| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Clarus Therapeutics Holdings, Inc. | 10%+ Owner | Common Stock | 3,528 | 20 Apr 2022 | Indirect | ||
| CLARUS THERAPEUTICS INC | 10%+ Owner | Common Stock | 3,528 | 20 Apr 2022 | Indirect |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000106299322010736-thomas-mcnerney-partners-lp-2022-04-20-restatement | Clarus Therapeutics Holdings, Inc. | 20 Apr 2022 | 6 | -$9,494,867 | 4/A | 10%+ Owner | 25 Apr 2022, 17:17 |
| CRXT | CLARUS THERAPEUTICS INC | 20 Apr 2022 | 6 | -$9,494,867 | 4 | 10%+ Owner | 21 Apr 2022, 19:04 |
| /report/000106299321008833-thomas-mcnerney-partners-lp-2021-09-10 | Clarus Therapeutics Holdings, Inc. | 10 Sep 2021 | 0 | $0 | 3 | 10%+ Owner | 21 Sep 2021, 21:18 |